Lancashire and South Cumbria
Formulary
4 Central nervous system
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
04-10-02 Nicotine dependence
Varenicline
Champix
®
Formulary
Tablets 0.5mg, 1mg
For community prescribing only
NICE TA123: Varenicline for smoking cessation
Links
MHRA Drug Safety Update Jan 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury
MHRA Drug SAfety Update Nov 2020: Bupropion (Zyban): risk of serotonin syndrome with use with other serotonergic drugs
MHRA safety update (Nov 2008)
NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
NICE TA123: Varenicline for smoking cessation
NICE TA123:Varenicline for smoking cessation
UKMI Q&A: Smoking and Drug Interactions
Key
Full Site